Insider Transactions in Q1 2022 at Renovacor, Inc. (RCOR)
Insider Transaction List (Q1 2022)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Feb 01
2022
|
Jonas Grossman Director |
BUY
Other acquisition or disposition
|
Direct |
40,000
+50.0%
|
-
|
|
Feb 01
2022
|
Gbolahan Amusa Director |
BUY
Other acquisition or disposition
|
Direct |
40,000
+50.0%
|
-
|
|
Jan 24
2022
|
Matthew Killeen Chief Scientific Officer |
BUY
Grant, award, or other acquisition
|
Direct |
5,275
+50.0%
|
-
|
|
Jan 24
2022
|
Magdalene Cook Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
70,825
+11.94%
|
-
|
|
Jan 24
2022
|
Marc Semigran Chief Medical Officer |
BUY
Grant, award, or other acquisition
|
Direct |
17,425
+24.87%
|
-
|
|
Jan 24
2022
|
Wendy F Dicicco Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
18,800
+44.84%
|
-
|
|
Jan 18
2022
|
Rtw Investments, LP > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
44,440
+1.46%
|
$355,520
$8.0 P/Share
|
|
Jan 14
2022
|
Rtw Investments, LP > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
150,723
+2.44%
|
$1,205,784
$8.0 P/Share
|
|
Jan 13
2022
|
Rtw Investments, LP > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
286
+0.01%
|
$2,002
$7.75 P/Share
|
|
Jan 12
2022
|
Rtw Investments, LP > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
1,950
+0.07%
|
$13,650
$7.67 P/Share
|
|
Jan 06
2022
|
Rtw Investments, LP > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
51,296
+1.8%
|
$410,368
$8.0 P/Share
|
|
Jan 05
2022
|
Rtw Investments, LP > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
100,195
+3.51%
|
$801,560
$8.0 P/Share
|
|
Jan 04
2022
|
Rtw Investments, LP > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
3
+0.0%
|
$24
$8.0 P/Share
|
|
Jan 03
2022
|
Rtw Investments, LP > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
441
+0.02%
|
$3,087
$7.95 P/Share
|